Loading clinical trials...
Loading clinical trials...
Prospective Randomized Phase-II Trial With Temsirolimus Versus Sunitinib in Previously Untreated Patients With Advanced or Metastatic Non-Clear Cell Renal Carcinoma
Conditions
Interventions
Temsirolimus
Sunitinib
Locations
14
Germany
Charité - Campus Virchow Klinikum
Berlin, Germany
Charité - Mitte
Berlin, Germany
Vivantes Klinikum am Urban
Berlin, Germany
Evangelische Kliniken Bonn gGmbH - Johanniter-Krankenhaus
Bonn, Germany
Universitätsklinikum Düsseldorf
Düsseldorf, Germany
Universitätsklinikum Essen
Essen, Germany
Start Date
July 1, 2009
Primary Completion Date
July 1, 2012
Last Updated
July 10, 2012
Lead Sponsor
Central European Society for Anticancer Drug Research
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions